6 Einträge gefunden

1. Ongoing retinal degeneration despite intraventricular enzyme replacement therapy with cerliponase alfa in late-infantile neuronal ceroid lipofuscinosis type 2 (CLN2 disease)

   1. Dulz, Simon
   2. Schwering, C
   3. Wildner, Jan
   4. Spartalis, Christoph
   5. Schuettauf, Frank
   6. Bartsch, Udo
   7. Wibbeler, Eva

   2023 - Forschungsinformationssystem des UKE
2. Visual perception and macular integrity in non-classical CLN2 disease

   1. Atiskova, Yevgeniya
   2. Wildner, Jan
   3. Wibbeler, Eva
   4. Nickel, Miriam
   5. Spitzer, Martin Stephan
   6. Schwering, Christoph
   7. Schulz, Angela

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
3. The Unified Batten Disease Rating Scale (UBDRS): Validation and reliability in an independent CLN3 disease sample

   1. Wibbeler, Eva
   2. Nickel, Miriam
   3. Schwering, Christoph
   4. Schulz, Angela
   5. Mink, Jonathan W

   2022 - Forschungsinformationssystem des UKE
4. Development of the "Hamburg Best Practice Guidelines for ICV-Enzyme Replacement therapy (ERT) in CLN2 Disease" Based on 6 Years Treatment Experience in 48 Patients

   1. Schwering, Christoph
   2. Kammler, Gertrud
   3. Wibbeler, Eva
   4. Christner, Martin
   5. Knobloch, Johannes K-M
   6. Nickel, Miriam
   7. Denecke, Jonas

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
5. An ophthalmic rating scale to assess ocular involvement in juvenile CLN3 disease

   1. Dulz, Simon
   2. Atiskova, Yevgeniya
   3. Wibbeler, Eva
   4. Wildner, Jan Einar
   5. Wagenfeld, Lars
   6. Schwering, Christoph
   7. Nickel, Miriam

   2020 - Forschungsinformationssystem des UKE
6. Cardiac pathology in neuronal ceroid lipofuscinoses (NCL): More than a mere co-morbidity

   1. Rietdorf, Katja
   2. Coode, Emily E
   3. Schulz, Angela
   4. Wibbeler, Eva
   5. Bootman, Martin D
   6. Ostergaard, John R

   2020 - Forschungsinformationssystem des UKE